Novel nutriceuticals relax airway smooth muscle and decrease inflammation in allergic lung disease

Narrative Asthma is a chronic airway disease characterized by reversible airway obstruction and inflammation. Despite currently therapies, up to 50% of asthmatics have incomplete control of their symptoms. We have identified potential novel therapeutics that simultaneously target two key pathological aspects of asthma: airway constriction and lung inflammation.